Biotechnology & Genetics
Gene editing advancements promise new treatments for complex diseases
CRISPR-Cas12a2 has selectively killed cells with a cancer-causing mutation, leaving healthy cells unaffected, according to Utah State University .
Maria Flores·June 12, 2026
